Treatment of prostate cancer, prostate cancer treatment complex, changeable. Including: active surveillance, surgery, radiotherapy, endocrine therapy and chemotherapy. However, the treatment for each patient should be individualized, doctors and patients will discuss the advantages of various treatments and not enough to determine the best treatment.
(A) active surveillance of prostate cancer
Refers to the process of active monitoring of prostate cancer, in the event of disease progression or when the clinical symptoms to other treatment. Can be used as appropriate for early prostate cancer and advanced prostate cancer, but for actively monitoring the patient should be closely followed up every 3 months, referral, check the prostate specific antigen, digital rectal examination, if necessary, shorten the time of referral.
(B) prostate cancer radical prostatectomy
The treatment of localized prostate cancer, the most effective way, for the life expectancy of patients more than 10 years, is the preferred method of treatment.
Treatment of prostate cancer (c) prostate cancer radiotherapy
Divided into external radiation therapy and brachytherapy for prostate cancer can not tolerate radical surgery for localized prostate cancer. External radiation therapy of advanced prostate cancer can also be used as palliative treatment.
(D) chemotherapy for prostate cancer
Can be used for hormone refractory prostate cancer treatment has been shown to extend the hormone refractory prostate cancer survival, therefore, hormone refractory prostate cancer patients, such as the conditions are right, should be actively line chemotherapy, the treatment should not be afraid side effects and lose the last opportunity for treatment.
Treatment of prostate cancer, (e) endocrine therapy for prostate cancer
Including the inhibition of Ku intoxicated secretion (surgical castration or medical castration), and blocking androgen receptor binding, can be used for the treatment of advanced prostate cancer because prostate cancer cell growth and the need to rely on male hormones, so the majority of endocrine therapy patients with prostate cancer are effective.